The Analyst Verdict: Lyell Immunopharma In The Eyes Of 4 Experts

BenzingaNov 12 20:00

HC Wainwright & Co. Reiterates Neutral on Lyell Immunopharma, Maintains $1 Price Target

BenzingaNov 12 19:45 · Ratings

Mitchell Kapoor Maintains Hold Rating on Lyell Immunopharma Amid Promising IMPT-314 Results and Market Challenges

TipRanksNov 12 19:16 · Ratings

Positive Week for Lyell Immunopharma, Inc. (NASDAQ:LYEL) Institutional Investors Who Lost 26% Over the Past Year

Simply Wall StNov 10 21:09

Lyell Immunopharma: Q3 Earnings Snapshot

Yahoo FinanceNov 8 06:22

Lyell Immunopharma 3Q Loss/Shr $44.6M >LYEL

Dow JonesNov 8 05:36